isirv Antiviral Group
Obtaining Neuraminidase Inhibitors for testing
Pure substances of each of the neuraminidase inhibitors can be obtained for laboratory testing of inhibitor sensitivity by contacting the manufacturers directly:
To obtain oseltamivir phosphate (pro-drug) and/or the active metabolite (oseltamivir carboxylate) from Roche, please complete the attached form
and return to the email address specified on the form.To obtain the pure zanamivir, please complete the attached form and send it to Lorraine.X.Bray@gsk.com
and send it to Lorraine.X.Bray@gsk.comIf the susceptibitlity testing identifies a potentially resistant strain of influenza virus, this information should be reported to Phillip Yates, GlaxoSmithKline Research and Development, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK (telephone: +44 (0)1438 763887), e-mail: phil.j.yates@gsk.com and a sample sent for confirmatory testing to Dr Jennifer McKimm-Breschkin, Biomolecular Research Institute, 343 Royal Parade, Parkville, Australia 3052. e-mail: Jennifer.McKimm-Breschkin@csiro.au
Links to Neuraminidase Inhibitor Drug Technical Information
Technical information on oseltamivir [Tamiflu®] is available here. The Summary of Product Characteristics (SPC) for oseltamivir is available here.
Technical information on zanamivir [Relenza®] is available here
For general information on oseltamivir, click here
For general information on zanamivir, click here
For general information on laninamivir, click here
For general information on peramivir, click here